newsfilter
← Latest News
GlobeNewswire·

Diffusion Pharmaceuticals Completes Enrollment and Dosing in TCOM Study

CHARLOTTESVILLE, Va., March 25, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), an innovative biopharmaceutical company developing novel...